Skip to main content
Clinical Trials/NCT06370481
NCT06370481RecruitingNot Applicable

HIV, Equity, and Addiction Training (HEAT) Program

University of Alabama at Birmingham2 sites in 1 country30 target enrollmentStarted: January 29, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
30
Locations
2
Primary Endpoint
Percent of participants who have a follow-up healthcare visit

Study Overview

Brief Summary

This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.

Detailed Description

The contemporary drug crisis and the COVID-19 pandemic have exposed the complex syndemics of addiction and infectious diseases: rising rates of substance use disorder (SUD) have outpaced our ability to respond with a limited healthcare workforce and public health capacity. SUD is increasing in those living with and at risk for HIV, and infectious consequences of SUD, like hepatitis C, have continued, unmitigated, in rural parts of the U.S. where many states lack Medicaid expansion, syringe service programs, and public health infrastructure to respond to the drug crisis and comorbid infections. Systemic racism and regressive policies in the Deep South criminalize people who use drugs, creating additional barriers to care, HIV prevention, and addiction treatment. As a result, people who use drugs rarely receive comprehensive addiction and HIV treatment. Yet telemedicine has the potential to overcome these barriers and bypass the constraints of a brick-and-mortar clinic to link vulnerable people, including those with HIV, to care. Although telemedicine has become mainstream in recent years, few studies have evaluated telemedicine for SUD in the Deep South from the perspective of patients and providers.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Receiving services at HIV clinics in Alabama
  • Reported opioid and/or stimulant misuse
  • 18 years of age or older

Exclusion Criteria

  • Receipt of SUD clinical care other than through HIV provider/clinic in the last 3 months
  • Inability to engage in interviews independently without support (e.g., cognitive impairment)
  • Currently psychotic
  • Actively suicidal: presents with a suicide attempt or suicidal ideation

Arms & Interventions

Patients living with HIV and substance use

Experimental

Patients living with HIV and substance use, aged 18 and over. These participants are receiving services at HIV clinics in Alabama and must have reported opioid and/or stimulant misuse.

Intervention: Telemedicine (Other)

Patients living with HIV and substance use

Experimental

Patients living with HIV and substance use, aged 18 and over. These participants are receiving services at HIV clinics in Alabama and must have reported opioid and/or stimulant misuse.

Intervention: Standard of care (Other)

Outcomes

Primary Outcomes

Percent of participants who have a follow-up healthcare visit

Time Frame: 1 month, 2 months, 3 months

Follow up visit for care (either telemedicine or in person)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ellen Eaton

Associate Professor

University of Alabama at Birmingham

Study Sites (2)

Loading locations...

Similar Trials